United States v. Carr

83 F.4th 267
CourtCourt of Appeals for the Fifth Circuit
DecidedSeptember 26, 2023
Docket22-20337
StatusPublished
Cited by2 cases

This text of 83 F.4th 267 (United States v. Carr) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Carr, 83 F.4th 267 (5th Cir. 2023).

Opinion

Case: 22-20337 Document: 00516909260 Page: 1 Date Filed: 09/26/2023

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit

____________ FILED September 26, 2023 No. 22-20337 Lyle W. Cayce ____________ Clerk

United States of America,

Plaintiff—Appellee,

versus

Clint Carr,

Defendant—Appellant. ______________________________

Appeal from the United States District Court for the Southern District of Texas USDC No. 4:18-CR-339-2 ______________________________

Before Duncan and Wilson, Circuit Judges, and Schroeder, District Judge. * Stuart Kyle Duncan, Circuit Judge: A jury convicted Clint Carr of numerous federal drug offenses related to his ownership and operation of a Texas pharmacy that was, in reality, an illegal pill mill. On appeal, Carr’s arguments for overturning his convictions largely concern four audio recordings that, after being vetted by a government filter team, were turned over to the prosecution. Carr contends

_____________________ * District Judge of the Eastern District of Texas, sitting by designation. Case: 22-20337 Document: 00516909260 Page: 2 Date Filed: 09/26/2023

No. 22-20337

that the recordings intruded into privileged conversations with his attorney and prejudiced his defense and that, as a result, his indictment should have been dismissed. Finding Carr’s arguments meritless, we affirm. I. Background A. Facts and Proceedings Clint Carr and his business partner, Dustin Curry, were co-owners of CC Pharmacy. They opened the original CC Pharmacy in Houston and later added “satellite” locations in Austin and Round Rock, Texas. In 2018, a Houston grand jury indicted Carr, Curry, and others for operating CC Pharmacy as a “pill mill.” Specifically, the indictment charged them with conspiring to unlawfully distribute controlled substances, unlawfully distributing and dispensing controlled substances (four counts), conspiring to launder monetary instruments, and engaging in monetary transactions in property derived from specified unlawful activity (two counts). See 21 U.S.C. § 846; 21 U.S.C. § 841(a)(1), (b)(1)(C), and 18 U.S.C. § 2; 18 U.S.C. § 1956(h); 18 U.S.C. § 1957 and 18 U.S.C. § 2. Curry pled guilty of conspiring to unlawfully distribute controlled substances and cooperated with the government. Carr went to trial. In March 2022, Curry and CC Pharmacy employees testified in detail during a five-day trial about the pharmacy’s criminal operations and Carr’s involvement. The evidence showed the pharmacy was a voluminous and lucrative operation. From May 2016 to November 2017, it filled 18,327 fake prescriptions and dispensed 1,685,400 units of controlled substances including hydrocodone, oxycodone, Xanax, codeine cough syrup, and Soma. This generated at least $5.58 million in revenue. Carr’s basic defense at trial was that, while he “undoubtedly lied to drug suppliers, pharmacy inspectors, and employees,” nonetheless “it was not outside the realm of plausibility that [he] was in fact a naïve and foolish

2 Case: 22-20337 Document: 00516909260 Page: 3 Date Filed: 09/26/2023

participant but not a conspirator.” He concedes, however, “[t]hat CC Pharmacy was unlawfully distributing controlled substances,” and that the government “overwhelmingly” proved this. The jury found Carr guilty on all counts. He was sentenced to 240 months in prison to be followed by three years of supervised release. B. The Recordings Most of Carr’s appellate arguments concern four audio recordings, which he contends violated his attorney-client privilege and prejudiced his defense. Although none were introduced at trial, we provide this detailed background on the recordings in order to fully address Carr’s arguments. Two years before trial, in March 2020, Carr agreed to allow a government filter team to review potentially privileged evidence seized from CC Pharmacy. While all this evidence was to be released to the defense, none was to be released to the prosecution until “cleared” by the filter team. During their review, the filter team found four audio recordings that included either conversations with CC Pharmacy’s attorney, Don Lewis (who died in 2020), or discussions about advice received from Lewis. Recording 1 captures an August 15, 2017, conversation between Carr, Curry, and Lewis. Lewis advises Carr and Curry how to respond to the Drug Enforcement Administration’s (DEA) seizure of drugs illegally transported by pharmacy employee Jeremy Newberry. After this discussion, Carr emailed pharmacist Megan Hanson, instructing her to falsely tell the DEA that Newberry was authorized to transport the drugs but had left the requisite DEA Form 222 on the pharmacy printer. Recording 2 captures a conversation between Carr, Curry, and Newberry, also on August 15, 2017. Carr tells Newberry that he and Curry

3 Case: 22-20337 Document: 00516909260 Page: 4 Date Filed: 09/26/2023

had spoken with Lewis and, as a result, were going to plant the DEA Form 222 on the pharmacy printer. Recording 3 captures an August 16, 2017, call between Curry and Newberry. Curry tells Newberry that he and Carr have talked to Lewis and have a “good gameplan on” to respond to the DEA seizure. Recording 4 is from July 18, 2017—i.e., a month before Recordings 1– 3. It captures a call between Carr, Curry, and CC Pharmacy pharmacists Hassan Barnes and Jose Sanchez. Barnes discusses advice received from Lewis in response to concerns raised by Sanchez about the legality of transferring drugs between CC Pharmacy locations. Barnes and Carr discuss further plans to consult with Lewis. In June 2021, the filter team gave Carr’s attorney copies of the four recordings. On September 1, 2021, they asked Carr’s attorney whether he intended to assert any privilege with respect to the recordings. The team explained that, in their view, any privilege was vitiated because CC Pharmacy had forfeited its charters and the State of Texas had terminated its registrations. When Carr’s lawyer did not respond, the filter team followed up on September 9, 2021, stating they planned to file a motion with the district court to authorize release of the recordings to the prosecution. After some back and forth, Carr’s lawyer finally said on September 14, 2021, that he intended to assert a privilege. On November 1, 2021, the filter team filed a motion with the district court to allow release of the recordings. The motion noted Carr’s opposition in a footnote. Because, as it later explained, the court mistakenly believed the motion was unopposed, it granted the motion the next day, before Carr responded. But the filter team did not immediately release the recordings. Rather, as they explained in an email to the prosecution, they waited to see whether Carr would respond or move for reconsideration. After two weeks

4 Case: 22-20337 Document: 00516909260 Page: 5 Date Filed: 09/26/2023

transpired with no action from Carr, the team finally released the recordings to the prosecution on November 16, 2021. On January 10, 2022, the government filed its trial exhibit list with the district court. The list included Recording 4, but none of the other recordings. The local rules required Carr to object to the list by January 17, 2022, but Carr did nothing.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Ryan
Fifth Circuit, 2025
United States v. Chiasson
90 F.4th 832 (Fifth Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
83 F.4th 267, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-carr-ca5-2023.